Research study Program year 2020 Source: CMS Open Payments

A 12-Week, Multicenter, Active-Treatment Extension Trial to Evaulate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

ClinicalTrials.gov NCT03594123

Research payments

$997,559

51 payments

Through program year 2020, $997,559 in research payments was reported against A 12-Week, Multicenter, Active-Treatment Extension Trial to Evaulate the Safety and Tolerability of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type, across 51 payments, paid by Otsuka Pharmaceutical Development & Commercialization, Inc..

Paid by: Otsuka Pharmaceutical Development & Commercialization, Inc.
ClinicalTrials.gov: NCT03594123

By program year

2 rows

Year	Kind	Amount	Payments
2020	Research	$782,394	34
2019	Research	$215,165	17

Breakdown

Who paid Research payments · program years 2019–2020

Otsuka Pharmaceutical Development & Commercialization, Inc. $997,559 51 payments

Who received the money Research payments · program years 2019–2020

Shreenath Clinical Service Organisation paid for research $369,721 2 payments
Health Care Family Rehab & Research Center Organisation paid for research $67,385 1 payment
Direct Helpers Research Center Organisation paid for research $59,639 1 payment
Galiz Research Organisation paid for research $49,068 2 payments
Sih Research Organisation paid for research $40,533 2 payments
Maxblue Research Organisation paid for research $38,403 1 payment
Bio Behavioral Health Organisation paid for research $31,708 2 payments
Integrity Clinical Research LLC Organisation paid for research $27,475 2 payments
Global Medical Institutes LLC Organisation paid for research $27,143 1 payment
Elias Research Associates LLC Organisation paid for research $23,955 3 payments

Usually the institution or organisation running the study, not a person.

Records

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

Principal investigators named

10 shown

Named on the study's payments. Being named is not being paid: the money in the figures above went to the recipients listed, not necessarily to these people.

What you are looking at

Research payments are tied to a study. Being named on a study as a principal investigator is reported separately from being paid as a recipient, and the two are not the same thing — a named investigator has not necessarily received the money.